Investigational new drugs for the treatment of resistant pneumococcal infections

Author： Hoffman-Roberts Holly L C Babcock Emily Mitropoulos Isaac F

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.8, 2005-08, pp. : 973-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational drugs for the treatment of allergic rhinitis

By Castillo Jamee Dimov Vesselin

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 823-836

Informa Healthcare

Access to resources Recommend Favorite

New investigational drugs for androgenetic alopecia

By Valente Duarte de Sousa Isabel Cristina Tosti Antonella

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 5, 2013-05 ,pp. : 573-589

Informa Healthcare

Access to resources Recommend Favorite

Investigational New Drugs, Volume 25, Number 1

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 283-283

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy of mycobacterial infections: molecular action of established drugs and investigational agents

By Chopra I.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 2, 1998-02 ,pp. : 253-255

Informa Healthcare

Access to resources Recommend Favorite

New-generation platinum drugs in the treatment of cisplatin-resistant cancers

By McKeage Mark J

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1033-1046

Informa Healthcare

Access to resources Recommend Favorite